Cas No.: | 2828433-08-3 |
Chemical Name: | (S)-1-((S)-1-((S)-2-Amino-3-methylbutanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylic acid trifluoroacetate |
Synonyms: | (S)-1-((S)-1-((S)-2-Amino-3-methylbutanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylic acid trifluoroacetate;H-Val-Pro-Pro-OH TFA;CS-0077836;G16510;VPP TFA;2828433-08-3;HY-114161A;H-Val-Pro-Pro-OH (TFA);(2S)-1-[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid;2,2,2-trifluoroacetic acid;MS-27486 |
SMILES: | C(F)(F)(F)C(=O)O.C(N1CCC[C@H]1C(=O)O)([C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)=O |
Formula: | C17H26F3N3O6 |
M.Wt: | 425.400055408478 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | In Vitro H-Val-Pro-Pro-OH (TFA), a proline peptides derivative, could inhibit Angiotensin I converting enzyme (ACE), with an IC50 of 9 μM. H-Val-Pro-Pro-OH (TFA) could enhance insulin sensitivity and prevent insulin resistance in 3T3-F442A pre-adipocytes. H-Val-Pro-Pro-OH (TFA) also has anti-hypertensive and anti-inflammatory functions. H-Val-Pro-Pro-OH (TFA) further enhances the expression of glucose transporter 4 (GLUT4) in adipocytes and restores glucose uptake in TNF-treated adipocytes. |